Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAFE trial of shortened antibiotic duration for complicated Staphylococcus aureus bacteremia
NL-OMON59943Phase 3Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of clindamycin in Staphylococcal bacteremia (2 arms), sponsored by Amsterdam University Medical Center. Started Aug 2020; status: completed.
02
Drugs
clindamycin
03
Conditions
Staphylococcal bacteremia
Beyond the preview
Go deeper on NL-OMON59943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59943.